Web News Insider
-
Thyroid Eye Disease Affects 16 in 100,000 Women Yearly, Smoking Multiplies Risk
Thyroid eye disease, linked to Graves’ disease, occurs in 16 per 100,000 women annually, with smoking increasing risk nearly eightfold and severe…
-
Generalized Myasthenia Gravis: Autoimmune Attack on Nerve-Muscle Junction Causes Progressive Weakness
Generalized myasthenia gravis is an autoimmune disorder where antibodies destroy acetylcholine receptors, leading to muscle weakness that worsens with activity and improves…
-
Zanidatamab’s Dual-Targeting Design Offers Alternative To Trastuzumab Deruxtecan
Zanidatamab’s unique mechanism and clinical data show promise for HER2-positive cancer treatment
-
How our AI Research team uses AI Runtime
SAN FRANCISCO, October 16 — Databricks’ AI Research team shared how they use the company’s own AI Runtime to power their model…
-
FDA Approves Zanvastro, the First Drug for the Rare Brain Disorder Alexander Disease
Madison, October 16 — The US Food and Drug Administration has approved Zanvastro, the first drug designed to directly treat Alexander disease,…
-
NCCN Adds Anktiva Plus BCG for Papillary-Only, BCG-Unresponsive Bladder Cancer
Silver Spring, October 16 — On October 14, 2026, the U.S. Food and Drug Administration approved an expanded use of nogapendekin alfa…
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
The landmark trial published in NEJM found Dexcom G7 users achieved 0.9% greater A1C reduction versus routine care, with five more hours…
-
Cancer Researchers Face Funding Gaps and Scientific Hurdles as Personal Stories Drive Public Support
Despite rising prevention knowledge and fundraising success, scientists cite funding instability and complex tumor biology as key barriers to progress in cancer…
-
FDA expands Anktiva approval to cover papillary-only bladder cancer, first treatment for this group
The FDA has broadened Anktiva’s use with BCG to include patients with BCG-unresponsive, high-grade papillary-only non-muscle-invasive bladder cancer, offering a bladder-preserving option…
-
Weight-Loss Drugs Linked to Less Drinking in Study of 14,000 WeightWatchers Members
WASHINGTON, October 15 — A national survey published in JAMA Psychiatry reveals that nearly half of adults using GLP-1 receptor agonists like…
-
Washington Calls It a Historic Boom, But Mortgage Rates Tell a Different Story
WASHINGTON, October 15 — The 30-year fixed mortgage rate climbed to 7.40% on October 8, up 0.69 percentage points from 6.71% a…
-
Google Overhauls AI Studio With a Build Tool for One-Click App Deployment
Mountain View, October 15 — Google has announced a significant update to its Google Play platform, aimed at simplifying the process for…
-
Polish Defense Minister Calls on US Industry to Build European Facilities to Strengthen NATO Supply Chains
WARSAW, October 15 — Poland’s defense minister Władysław Kosiniak-Kamysz on Monday called for US defense companies to establish production lines and maintenance…
-
Supreme Court Takes Up Musk DOGE Records Lawsuit
WASHINGTON, October 14 — The Supreme Court has agreed to hear arguments in a lawsuit filed by Citizens for Responsibility and Ethics…
-
Two FDA-Approved MASH Drugs Give Patients New Options, and UCLA Health Offers a Way to Choose
LOS ANGELES, October 14 — On this date, the U.S. Food and Drug Administration granted approval to two drugs, Resmetirom and semaglutide,…
-
Justice Department Trade Fraud Task Force Passes $1 Billion and Charges Gold Jewelry Importers
WASHINGTON, October 14 — The Department of Justice has reinforced its commitment to combating global trade fraud with a follow-up directive issued…
-
WHO Says 1.1 Billion Live With Obesity as Sleep, Stress and Hormones Shape Weight
Gurugram, June 19 — The World Health Organization now calls obesity one of the fastest-growing health concerns globally. That label carries weight.…
-
Emergency Funds: The 3-6 Month Rule Is a Starting Point, Advisers Say, Not a Formula
NEW YORK, October 7 — Financial advisors consistently recommend maintaining an emergency fund covering three to six months of essential living expenses…
-
UN General Assembly Adopts Pandemic Declaration by Vote After Consensus Is Blocked
NEW YORK, October 14 — The World Health Organization (WHO) welcomed the adoption by the United Nations General Assembly (UNGA) of the…
-
UK Homeowners Delay Renovations as Costs Outstrip Savings, Survey Finds
Manila, October 13 — Homeowners across Asia are delaying or canceling renovation projects as the cost of home improvements has risen to…
-
Moody Warns Nixon’s Agenda Threatens Florida’s Economic Strength in Senate Race
TALLAHASSEE, October 12 — In the upcoming Nov 3 general election, Florida’s incumbent Senator Ashley Moody, a Republican, faces Democratic state Rep.…
-
SIA Report Finds U.S. Chip Supply Chain Leans More on China Than Headquarters Data Shows
WASHINGTON, October 12 — The Semiconductor Industry Association (SIA) has released a new report titled ‘Understanding Dependencies in the U.S. Semiconductor Supply…
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
London, October 11, 2026 In the United Kingdom, households with £10,000 in bank accounts are being urged to act swiftly to avoid…
-
Nationwide Offers Customers up to £500 in Competitive Deal
LONDON, October 2 — Nationwide Building Society’s two-year variable tracker rate mortgage, at 80% loan-to-value, has been named a Best Buy with…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992